ReviewFrontiers in veterinary science2026
Mitigating antimicrobial resistance in the animal industry: reduction strategies and alternatives to antibiotics.
Review in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) has become a worldwide issue of human and animal health, food security, and environmental sustainability due to its seriousness and the challenge of resolving it. Widespread utilization of antibiotics in the animal industry for metaphylactic, therapeutic, production, and prophylactic purposes has significantly contributed to the spread and emergence of antibiotic-resistant microorganisms. Food- producing animals are also deemed as good reservoirs of "antimicrobial resistance genes (ARGs) and antimicrobial- resistant bacteria (ARB)" that may contaminate humans through the food chain, environmental pathway, and direct contact. Moreover, the discharge of antibiotic residues into the soil and water systems enhances selective pressure among microbial communities, making AMR a nature of One Health. This review summarizes the major strategies to reduce antibiotics use in the animal industry, which include: better husbandry and biosecurity measures, vaccination, wise use of antimicrobials, manure and environmental management. Special attention is given to non-antibiotic options like probiotics, prebiotics, phytogenic compounds, organic acids, immunomodulators, and other feed-based or biological interventions that are emphasized to maintain animal health and productivity while reducing antibiotic use. Through a combination of these strategies in a One Health paradigm, this review outlines feasible and viable solutions to help curb the problem of AMR in the animal sector. Findings highlight the importance of concerted action by producers, veterinarians, policymakers, and researchers to decrease the reliance on antibiotics and protect human health and animal production systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.